Latest News

Elixirgen Therapeutics, Inc. raises $4 million in Series A funds

Elixirgen Therapeutics, LLC now Elixirgen Therapeutics, Inc.

Elixirgen Therapeutics successfully concludes pre-IND meeting with FDA

Elixirgen, LLC forms subsidiary company Elixirgen Therapeutics, LLC

Elixirgen Signs License Agreement with National Institute on Aging

Elixirgen Announces License Agreement with Sumitomo Dainippon Pharma

New Down syndrome therapy discovered

Elixirgen awarded Investigator-Initiated Grant from MSCRF